LuisZeichner(Ostrosky-Zeichner)OstroskyMDFACP, FIDSA, FSHEA, FECMM
Infectious Disease • Houston, TXHealthcare Associated Infections, Transplant/Immunocompromised States
Professor and chief, Memorial Hermann Endowed Chair, Division of Infectious Diseases, University of Texas Medical School at Houston
Dr. Ostrosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431Fannin St
MSB 2112.F
Houston, TX 77030Phone+1 713-500-6733Fax+1 713-500-5495
Summary
- Professor of medicine and epidemiology, Memorial Hermann Endowed Chair, Vice-Chair of Medicine, Director, Laboratory of Mycology Research, Division Chief, Infectious Diseases, UTHealth. Chief Epidemiology Officer, Memorial Hermann. Senior Editor, Journal of Antimicrobial Chemotherapy. Assoc. Editor, Clinical Infectious Diseases. Past-President of the Mycoses Study Group. Consultant, FDA and CDC.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1999 - 2002
U Texas Med Sch1999 - 2002
Universidad Nacional Autonoma de MexicoClass of 1995, Honors
Certifications & Licensure
TX State Medical License 2002 - 2026
American Board of Medical QualityCMQ
Awards, Honors, & Recognition
- Fellow European Confederation of Medical Mycology
- Fellow American College of Physicians
- Fellow Infectious Diseases Society of America
- Join now to see all
Clinical Trials
- Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Start of enrollment: 2007 Aug 01
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Start of enrollment: 2017 Apr 01
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- Correction: Ellsworth, M.; Ostrosky-Zeichner, L. Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance.2020,, 324.Misti Ellsworth, Luis Ostrosky-Zeichner
Journal of Fungi. 2025-03-17 - Medical Mycology in the Modern Era.Alfred Luk, Luis Ostrosky-Zeichner
Infectious Disease Clinics of North America. 2025-03-01 - Evaluation of Certification Board of Infection Control and Epidemiology, Inc Certification in Infection Control (CIC) examination rates.Kayla E Ruch, Anabel Rodriguez, Luis Ostrosky-Zeichner, Eric L Brown
American Journal of Infection Control. 2025-03-01
Authored Content
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Using Blockchain to Develop a Novel Propensity Score for Candidemia and Invasive CandidiasisOctober 2018
Press Mentions
Low Vaccination Rates Fuel Largest Texas Measles Outbreak in 30 YearsFebruary 20th, 2025- This Is One of the Worst Flu Seasons in DecadesFebruary 12th, 2025
- Texas Has One of the Lowest Vaccination Rates in the U.S. Here's WhySeptember 19th, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
